Search - tctmd.com

Displaying 1 - 20 of 623

Sort: Relevancy | Date

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

Presentation ACC 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presenter: Dimytri Siqueira

March 29, 2026

News Daily News

Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On

Todd Neale

March 26, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

L.A. McKeown

March 17, 2026

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

Presentation THT Abstracts 2026

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Presenter: Rani Marhaba

March 02, 2026

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

Presentation TCT 2025

TCT 1521: Extremely Early Tricuspid Bioprosthetic Valve Degeneration: Diagnostic Evaluation and Successful Transcatheter Valve-in-Valve Intervention

Presenter: Mark Sonbol

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Challenging Surgical Valves for TAV in SAV: Mitraflow, Trifecta, Stentless Valves and Homografts

Presenter: Keith B. Allen

October 27, 2025

Presentation TCT 2025

Leaflet Modification: When and How?

Presenter: Pedro Arturo Villablanca

October 27, 2025

Presentation TCT 2025

Bioprosthetic Valve Fracture: Benefits and Risks

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Procedural Planning for ViV TAVR

Presenter: Chad Alan Kliger

October 27, 2025

Presentation TCT 2025

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

Presenter: Michael A. Borger

October 27, 2025

Presentation TCT 2025

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

Presenter: Frédéric Beaupré

October 27, 2025

Presentation TCT 2025

TCT 1226: Valve-in-Valve TAVR for Failed Trifecta Surgical Bioprosthetic Aortic Valves

Presenter: Matjaz Bunc

October 26, 2025

Presentation TCT 2025

Featured Clinical Research: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Presenter: Keith B. Allen

October 26, 2025

Advertisement

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On

What’s Going to Be Hot at ACC 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

Experience Matters as Ross Procedure Gains Popularity in North America

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

TCT 1521: Extremely Early Tricuspid Bioprosthetic Valve Degeneration: Diagnostic Evaluation and Successful Transcatheter Valve-in-Valve Intervention

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Challenging Surgical Valves for TAV in SAV: Mitraflow, Trifecta, Stentless Valves and Homografts

Leaflet Modification: When and How?

Bioprosthetic Valve Fracture: Benefits and Risks

Procedural Planning for ViV TAVR

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

TCT 1226: Valve-in-Valve TAVR for Failed Trifecta Surgical Bioprosthetic Aortic Valves

Featured Clinical Research: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content